RetinalGenix Technologies (RTGN) Operating Expenses (2020 - 2026)

RetinalGenix Technologies (RTGN) has 7 years of Operating Expenses data on file, last reported at $589229.0 in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses changed 0.49% year-over-year to $589229.0; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (down 12.0% YoY), and the FY2025 full-year result was $2.4 million, down 43.84% from the prior year.
• Operating Expenses declined to $589229.0 in Q1 2026, from $622059.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.5 million in Q3 2022 to a low of $351183.0 in Q2 2023.
• A 5-year average of $783923.8 and a median of $622059.0 in 2025 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 1908.18% in 2022 and slumped 72.66% in 2025, its largest moves.
• Tracing RTGN's Operating Expenses over 5 years: stood at $674006.0 in 2022, then fell by 19.78% to $540676.0 in 2023, then jumped by 60.18% to $866067.0 in 2024, then declined by 28.17% to $622059.0 in 2025, then decreased by 5.28% to $589229.0 in 2026.
• Business Quant data shows RTGN's Operating Expenses at $589229.0 in Q1 2026, $622059.0 in Q4 2025, and $567833.0 in Q3 2025.